Published in Diabetes Care on January 01, 1995
The Charcot foot in diabetes. Diabetes Care (2011) 1.35
Charcot osteoarthropathy in diabetes: A brief review with an emphasis on clinical practice. World J Diabetes (2011) 1.20
Inflammatory osteolysis in diabetic neuropathic (charcot) arthropathies of the foot. Phys Ther (2008) 1.11
Volumetric quantitative computed tomography measurement precision for volumes and densities of tarsal and metatarsal bones. J Clin Densitom (2011) 1.07
Bone mineral density during total contact cast immobilization for a patient with neuropathic (Charcot) arthropathy. Phys Ther (2005) 1.05
Assessing decreased sensation and increased sensory phenomena in diabetic polyneuropathies. Diabetes (2013) 1.00
Inpatient management of diabetic foot disorders: a clinical guide. Diabetes Care (2013) 0.95
Diabetic neuropathy in older adults. Clin Geriatr Med (2008) 0.94
A literature-based guide to the conservative and surgical management of the acute Charcot foot and ankle. Diabet Foot Ankle (2015) 0.88
Progression of foot deformity in Charcot neuropathic osteoarthropathy. J Bone Joint Surg Am (2013) 0.87
Etiology, pathophysiology and classifications of the diabetic Charcot foot. Diabet Foot Ankle (2013) 0.82
A prospective study of calcaneal bone mineral density in acute Charcot osteoarthropathy. Diabetes Care (2010) 0.81
Impact of Charcot neuroarthropathy on metatarsal bone mineral density and geometric strength indices. Bone (2012) 0.81
Utilization of advanced modalities in the management of diabetic Charcot neuroarthropathy. J Diabetes Sci Technol (2010) 0.79
Conservative and surgical treatment of the chronic Charcot foot and ankle. Diabet Foot Ankle (2013) 0.78
Neuropathy and the vascular-bone axis in diabetes: lessons from Charcot osteoarthropathy. Osteoporos Int (2013) 0.76
Cutaneous structural and biochemical correlates of foot complications in high-risk diabetes. Diabetes Care (2012) 0.75
Spontaneous Renal Artery Dissection as a Cause of Acute Renal Infarction: Clinical and MDCT Findings. J Korean Med Sci (2017) 0.75
A comparative study of zoledronic acid and once weekly Alendronate in the management of acute Charcot arthropathy of foot in patients with diabetes mellitus. Indian J Endocrinol Metab (2013) 0.75
A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia (1993) 4.43
Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care (1999) 3.27
Low bone mineral density in adults with cystic fibrosis. Thorax (1999) 2.94
A feasibility study of the use of continuous subcutaneous insulin infusion in a diabetic clinic: patients' choice of treatment. Diabet Med (1984) 2.84
Predicting risk of diabetic ketoacidosis in patients using continuous subcutaneous insulin infusion. Br Med J (Clin Res Ed) (1986) 2.79
Off-loading the diabetic foot wound: a randomized clinical trial. Diabetes Care (2001) 2.60
The risk of foot ulceration in diabetic patients with high foot pressure: a prospective study. Diabetologia (1992) 2.38
Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial. Lancet (1999) 2.37
The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study. Diabetes Care (1994) 2.36
Severe bone pain after intravenous pamidronate in adult patients with cystic fibrosis. Lancet (1998) 2.30
Medial arterial calcification in the feet of diabetic patients and matched non-diabetic control subjects. Diabetologia (1993) 2.05
DNA chips: an array of possibilities. Nat Biotechnol (1998) 1.95
The effects of ulcer size and site, patient's age, sex and type and duration of diabetes on the outcome of diabetic foot ulcers. Diabet Med (2001) 1.91
The application of clinical guidelines for skull radiography in the Accident and Emergency department: theory and practice. Clin Radiol (1990) 1.90
Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care (2001) 1.82
Determinants of HAART discontinuation among injection drug users. AIDS Care (2005) 1.74
Pain relief by electrical stimulation of the central gray matter in humans and its reversal by naloxone. Science (1977) 1.62
Severe hyperkalaemia and ketoacidosis during routine treatment with an insulin pump. Br Med J (Clin Res Ed) (1985) 1.62
Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy. Diabetes Care (1983) 1.61
A role for mitogen-activated protein kinases in the etiology of diabetic neuropathy. FASEB J (2001) 1.59
The association between callus formation, high pressures and neuropathy in diabetic foot ulceration. Diabet Med (1996) 1.56
The prevalence of foot ulceration and its correlates in type 2 diabetic patients: a population-based study. Diabet Med (1994) 1.53
Early effects of ethinyloestradiol and norethisterone treatment in post-menopausal women on bone resorption and calcium regulating hormones. Clin Sci (Lond) (1985) 1.47
High-pressure liquid chromatographic determination of ranitidine, a new H2-receptor antagonist, in plasma and urine. J Pharm Sci (1980) 1.46
Hypertrichosis due to minoxidil. Br J Dermatol (1979) 1.45
Assessment of in vitro thyroid function tests in 100 consecutive patients referred to a thyroid clinic. Clin Endocrinol (Oxf) (1973) 1.45
Malignant pilomatrixoma with bone metastasis. Histopathology (1993) 1.43
The tactile circumferential discriminator. A new, simple screening device to identify diabetic patients at risk of foot ulceration. Diabetes Care (1997) 1.42
Aetiopathogenesis and management of impotence in diabetic males: four years experience from a combined clinic. Diabet Med (1995) 1.41
The relationship of static foot structure to dynamic foot function. J Biomech (1997) 1.40
Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins. Arterioscler Thromb Vasc Biol (1995) 1.40
Relationship of limited joint mobility to abnormal foot pressures and diabetic foot ulceration. Diabetes Care (1991) 1.39
Severe insulin resistance, diabetes mellitus, hypertriglyceridemia, and pseudoacromegaly. J Clin Endocrinol Metab (1996) 1.39
Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration. Diabetes Care (1998) 1.37
Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus. Atherosclerosis (1998) 1.36
Bone loss in celiac disease is related to secondary hyperparathyroidism. J Bone Miner Res (1999) 1.36
A comparison of two diabetic foot ulcer classification systems: the Wagner and the University of Texas wound classification systems. Diabetes Care (2001) 1.34
Microangiopathy in human diabetic neuropathy: relationship between capillary abnormalities and the severity of neuropathy. Diabetologia (1989) 1.32
Semmes-Weinstein monofilaments: a simple, effective and inexpensive screening device for identifying diabetic patients at risk of foot ulceration. Diabetes Res Clin Pract (1991) 1.32
Jugular vein thrombosis associated with distant malignancy. Postgrad Med J (1988) 1.32
Dynamic foot pressure and other studies as diagnostic and management aids in diabetic neuropathy. Diabetes Care (1983) 1.29
Molecular and functional characteristics of ovarian surface epithelial cells transformed by KrasG12D and loss of Pten in a mouse model in vivo. Oncogene (2011) 1.29
A molecular characterization of Clostridium difficile isolates from humans, animals and their environments. Epidemiol Infect (1993) 1.28
Quantitative ultrasound of the heel and fracture risk assessment: an updated meta-analysis. Osteoporos Int (2011) 1.28
Vertebral shape: automatic measurement with active shape models. Radiology (1999) 1.27
Nicotine chewing gum in general practice: effect of follow up appointments. Br Med J (Clin Res Ed) (1985) 1.26
Venous oxygenation in the diabetic neuropathic foot: evidence of arteriovenous shunting? Diabetologia (1982) 1.25
Bone geometry and density in the skeleton of pre-pubertal gymnasts and school children. Bone (2005) 1.25
A measure of treatment satisfaction designed specifically for people with insulin-dependent diabetes. Diabet Med (1988) 1.24
Current perception thresholds: a new, quick, and reproducible method for the assessment of peripheral neuropathy in diabetes mellitus. Diabetologia (1989) 1.23
Messenger RNA editing of the human serotonin 5-HT2C receptor. Neuropsychopharmacology (1999) 1.23
Radiographic features of lumbar disc degeneration and bone mineral density in men and women. Ann Rheum Dis (2005) 1.22
Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial. Diabetologia (2001) 1.20
Sarcopenia and its relationship with bone mineral density in middle-aged and elderly European men. Osteoporos Int (2012) 1.19
Sural nerve fibre pathology in diabetic patients with mild neuropathy: relationship to pain, quantitative sensory testing and peripheral nerve electrophysiology. Acta Neuropathol (2001) 1.19
A randomized, double-blind study comparing the effects of beclomethasone and fluticasone on bone density over two years. Eur Respir J (1999) 1.19
A randomized, controlled trial of vitamin D supplementation upon musculoskeletal health in postmenarchal females. J Clin Endocrinol Metab (2010) 1.18
Chronic thalamic stimulation for the control of facial anesthesia dolorosa. Arch Neurol (1973) 1.18
Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Troglitazone Study Group. Diabetologia (1996) 1.17
Sensory system involvement in infantile spinal muscular atrophy. J Neurol Sci (1975) 1.17
Plantar tissue thickness is related to peak plantar pressure in the high-risk diabetic foot. Diabetes Care (2001) 1.16
Acupuncture for the treatment of chronic painful peripheral diabetic neuropathy: a long-term study. Diabetes Res Clin Pract (1998) 1.16
Recommendations for thresholds for cortical bone geometry and density measurement by peripheral quantitative computed tomography. Calcif Tissue Int (2005) 1.15
Localization of estrogen receptor beta protein expression in adult human bone. J Bone Miner Res (2001) 1.15
Brain chirps: spectrographic signatures of epileptic seizures. Clin Neurophysiol (2000) 1.14
Dose dependent response of symptoms, pituitary, and bone to transdermal oestrogen in postmenopausal women. Br Med J (Clin Res Ed) (1986) 1.14
Relationship between growth hormone (GH) status, serum leptin and body composition in healthy and GH deficient elderly subjects. Clin Endocrinol (Oxf) (1997) 1.14
A prospective study of change in bone mineral density over one year in adults with cystic fibrosis. Thorax (2002) 1.13
The short insulin tolerance test for determination of insulin sensitivity: a comparison with the euglycaemic clamp. Diabet Med (1992) 1.13
Diabetic thoracic polyradiculopathy presenting as abdominal swelling. Br Med J (Clin Res Ed) (1984) 1.12
Bisphosphonates: a new treatment for diabetic Charcot neuroarthropathy? Diabet Med (1994) 1.12
Imaging of trabecular bone structure in osteoporosis. Eur Radiol (1999) 1.12
Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic. Diabet Med (1999) 1.11
The empty sella syndrome. J Neurosurg (1968) 1.10
Drug complience in hypertensive patients. Br Med J (1977) 1.10
Gait abnormalities in diabetic neuropathy. Diabetes Care (1997) 1.10
Mandibular bone mineral density as a predictor of skeletal osteoporosis. Br J Radiol (1996) 1.10
Psychological status of diabetic people with or without lower limb disability. Diabetes Res Clin Pract (1996) 1.10
Molecular scanning of the insulin receptor gene in syndromes of insulin resistance. Diabetes (1994) 1.08
Mobility status and bone density in cerebral palsy. Arch Dis Child (1996) 1.08
Do people with diabetes wear their prescribed footwear? Diabet Med (1996) 1.08
Gastrointestinal carriage of Clostridium difficile in cats and dogs attending veterinary clinics. Epidemiol Infect (1991) 1.08
Reduced bone mineral density in patients with adult onset growth hormone deficiency. J Clin Endocrinol Metab (1994) 1.08
Adult polyglucosan body disease (APBD). J Neuropathol Exp Neurol (1988) 1.08
Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency. J Clin Endocrinol Metab (1993) 1.08
A negative search for a paramyxoviral etiology of Paget's disease of bone: molecular, immunological, and ultrastructural studies in UK patients. J Bone Miner Res (2000) 1.07
A transcervical transclival approach to the ventral surface of the brain stem for removal of a clivus chordoma. J Neurosurg (1966) 1.07
Differences in peripheral and autonomic nerve function measurements in painful and painless neuropathy. A clinical study. Diabetes Care (1994) 1.06
Painful neuropathy and foot ulceration in diabetic patients. Diabetes Care (1993) 1.06
Benefits of a multidisciplinary approach in the management of recurrent diabetic foot ulceration in Lithuania: a prospective study. Diabetes Care (1999) 1.06
The prevalence of symptomatic, diabetic neuropathy in an insulin-treated population. Diabetes Care (1985) 1.06
Sural nerve oxygen tension in diabetes. Br Med J (Clin Res Ed) (1986) 1.06
Lack of insulin-like growth factor 1 (IGF1) in the basal keratinocyte layer of diabetic skin and diabetic foot ulcers. J Pathol (2000) 1.05
The Neurometer: validation and comparison with conventional tests for diabetic neuropathy. Diabet Med (1991) 1.05